Funding provides for the acceleration of its internal growth strategy and the continued development of Reshape's weight-loss portfolio SAN CLEMENTE, CA / ACCESSWIRE / June 30, 2021 / ReShape ...
SAN CLEMENTE, Calif., Nov. 04, 2021 (GLOBE NEWSWIRE) -- ReShape Lifesciences Inc. (NASDAQ:RSLS), the premier physician-led weight loss and metabolic health-solutions company, today announced the ...
ReShape Lifesciences gains approval for its patent application called, "Intragastric Device (For Treating Obesity)." ReShape is trending across different social media platforms as its stock trades on ...
On July 8, 2024, ReShape Lifesciences Inc. entered into a definitive merger agreement with Vyome, under which ReShape and Vyome will combine in an all-stock transaction. At the closing of the merger, ...
Hive’s AI- and SMS-based Patient-Self-Service Technology to Manage Prospective Lap-Band® Leads From Initial Contact Through Surgical Consultation IRVINE, Calif., June 29, 2023 (GLOBE NEWSWIRE) -- ...
ReShape Lifesciences has received a Notice of Allowance from the U.S. Patent and Trademark Office for its patent application on a new Diabetes Neuromodulation system utilizing its vagal nerve block ...
LONDON, England—Anyone hoping that a third “tiebreaker” trial of the MitraClip against optimal medical therapy (OMT) would help clarify the role of transcatheter edge-to-edge repair (TEER) in heart ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results